Crsp analyst ratings
WebCRSP Analyst Ratings Consensus Buy Based on 23 analysts offering recommendations for 'CRSP' in the last 3 months. Analyst Firms Making Recommendations B OF A GLBL … WebCRSP Analyst Ratings Moderate Buy 17 Ratings 9 Buy 7 Hold 1 Sell Based on 17 analysts giving stock ratings to Crispr Therapeutics AG in the past 3 months CRSP …
Crsp analyst ratings
Did you know?
WebApr 13, 2024 · Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, CRISPR Therapeutics has a consensus rating of “Hold” and a consensus target price of $72.84. CRISPR Therapeutics Profile ( Get Rating)
WebApr 10, 2024 · According to 35 stock analysts, the average 12-month stock price forecast for CRSP stock is $ 85.88 , which predicts an increase of 89.16%. The lowest target is $ … Web2 days ago · CRISPR Therapeutics (CRSP) (Delayed Data from NSDQ) $44.80 USD +1.09 (2.49%) Updated Apr 5, 2024 03:59 PM ET After-Market: $44.60 -0.20 (-0.45%) 7:58 PM ET Add to portfolio Zacks Rank: 2-Buy 2...
WebView the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ. CRSP CRISPR Therapeutics AG … Web1 day ago · Three of ANEW's underlying holdings with notable upside to their analyst target prices are CRISPR Therapeutics AG (Symbol: CRSP), Veracyte Inc (Symbol: VCYT), …
WebThe commodity reached a new 52-week high and recorded its second-highest close in history, just below a record high of $2,051.50 established in 2024. Thanks to this advance, AU closed at $28.06 ...
Web1 day ago · CRISPR Therapeutics (CRSP) jumped Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating and a $72 per share target. Find out the reasons. corinna achenbachWebCRISPR Therapeutics AG research and ratings by Barron's. View CRSP revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. corinna accent tableWeb5 rows · See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, ... Find the latest CRISPR Therapeutics AG (CRSP) stock discussion in Yahoo … Interactive Chart for CRISPR Therapeutics AG (CRSP), analyze all the data with a … Get the detailed quarterly/annual income statement for CRISPR Therapeutics AG … Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or … See the company profile for CRISPR Therapeutics AG (CRSP) including … See CRISPR Therapeutics AG (CRSP) Environment, Social and Governance … Find out all the key statistics for CRISPR Therapeutics AG (CRSP), including … Find out the direct holders, institutional holders and mutual fund holders for … View the basic CRSP option chain and compare options of CRISPR … corinmethodWebAnalyst Ratings Average price target from 28 ratings: $ 86.40 Average score: Sell Under Hold Over Buy Full Ratings Open $45.63 Previous Close- YTD Change 12.52% 12 Month Change -32.63% Day... corinna a. hornWeb2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... fancy spiced rumWebApr 3, 2024 · Crispr Therapeutics AG (CRSP) In a report released today, Anthony Butler from EF Hutton reiterated a Buy rating on Crispr Therapeutics AG, with a price target of $75.00. The company’s shares ... corinna alstromer ricsWebCRSP CRISPR Therapeutics AG Analyst Estimates & Rating – WSJ CRISPR Therapeutics AG CRSP (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT … fancy spelling